Abstract
Duchenne muscular dystrophy (DMD) is a progressive, fatal pediatric disorder with significant burden on parents. Assessing disease impact can inform clinical interventions. Best-worst scaling (BWS) was used to elicit parental priorities among 16 short-term, DMD-related worries identified through community engagement. Respondents viewed 16 subsets of worries, identified using a balanced, incomplete block design, and identified the most and least worrying items. Priorities were assessed using best-worst scores (spanning +1 to −1) representing the relative number of times items were endorsed as most and least worrying. Independent-sample t-tests compared prioritization of parents with ambulatory and non-ambulatory children. Participants (n = 119) most prioritized worries about weakness progression (BW score = 0.64) and getting the right care over time (BW = 0.25). Compared to parents of non-ambulatory children, parents of ambulatory children more highly prioritized missing treatments (BW = 0.31 vs. 0.13, p < 0.001) and being a good enough parent (BW = 0.06 vs. −0.08, p = 0.010), and less prioritized child feeling like a burden (BW = −0.24 vs. −0.07, p < 0.001). Regardless of child’s disease stage, caregiver interventions should address the emotional impact of caring for a child with a progressive, fatal disease. We demonstrate an accessible, clinically-relevant approach to prioritize disease impact using BWS, which offers an alternative to the use of traditional rating/ranking scales.
Similar content being viewed by others
References
Accreditation Counsel for Genetic Counseling (2013). Practice-based competencies for genetic counselors. Retrieved from https://doi.org/www.gceducation.org/Documents/ACGC%20Core%20Competencies%20Brochure_13-Web-Revised-FINAL.pdf. Accessed December 2014.
Baines, T., & Wittkowski, A. (2013). A systematic review of the literature exploring illness perceptions in mental health utilising the self-regulation model. Journal of Clinical Psychology in Medical Settings, 20(3), 263–274.
Black, N. (2013). Patient reported outcome measures could help transform healthcare. British Medical Journal, 346, f167.
Borkovec, T. D., Robinson, E., Pruzinsky, T., & Dupree, J. A. (1983). Preliminary exploration of worry: some characteristics and processes. Behaviour Research and Therapy, 23, 481–482.
Boyer, F., Drame, M., Morrone, I., & Novella, J. L. (2006). Factors relating to carer burden for families of persons with muscular dystrophy. Journal of Rehabilitation Medicine, 38(5), 309–315.
Bridges, J. F., Hauber, A. B., Marshall, D., Lloyd, A., Prosser, L. A., Regier, D. A., Johnson, F. R., & Mauskopf, J. (2011). Conjoint analysis applications in health--a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value in Health, 14(4), 403–413.
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., et al. (2010). DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurology, 9(1), 77–93.
Creswell, J. W., Klassen, A. C., Plano Clark, V. L., & Smith, K. C. for the Office of Behavioral and Social Sciences Research. (2011). Best practices for mixed methods research in the health sciences. National Institutes of Health. Retrieved from https://doi.org/obssr.od.nih.gov/mixed_methods_research. Accessed December 2014.
Daoud, A., Dooley, J. M., & Gordon, K. E. (2004). Depression in parents of children with Duchenne muscular dystrophy. Pediatric Neurology, 31(1), 16–19.
dosReis, S., Ng, X., Frosch, E., Reeves, G., Cunningham, C., & Bridges, J. (2014). Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD: a pilot study. The Patient. doi:https://doi.org/10.1007/s40271-014-0098-4.
Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002). Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disorders, 12(10), 926–929.
Erdem, S., & Rigby, D. (2013). Investigating heterogeneity in the characterization of risks using best worst scaling. Risk Analysis, 33(9), 1728–1748.
Flanigan, K. M. (2014). Duchenne and Becker muscular dystrophies. Neurologic Clinics, 32(3), 671–688.
Fleishman, J. A. (2005). Methodology Report #15: Demographic and clinical variations in health status. Agency for Healthcare Research and Quality, Rockville, MD. Retrieved from https://doi.org/www.meps.ahrq.gov/data_files/publications/mr15/mr15.shtml. Accessed July 2015.
Flynn, T. N. (2010). Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling. Expert Review of Pharmacoeconomics & Outcomes Research, 10(3), 259–267.
Flynn, T. N., Louviere, J. J., Peters, T. J., & Coast, J. (2007). Best worst scaling: what it can do for health care research and how to do it. Journal of Health Economics, 26(1), 171–189.
Gallego, G., Bridges, J. F., Flynn, T., Blauvelt, B. M., & Niessen, L. W. (2012). Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. International Journal of Technology Assessment in Health Care, 28(3), 339–346.
Grewal, I., Lewis, J., Flynn, T., Brown, J., Bond, J., & Coast, J. (2006). Developing attributes for a generic quality of life measure for older people: preferences or capabilities? Social Science & Medicine, 62(8), 1891–1901.
Hale, E. D., Treharne, G. J., & Kitas, G. D. (2007). The common-sense model of self-regulation of health and illness: how can we use it to understand and respond to our patients’ needs? Rheumatology, 46, 904–906.
Hatzmann, J., Heymans, H. S., Ferrer-i-Carbonell, A., van Praag, B. M., & Grootenhuis, M. A. (2008). Hidden consequences of success in pediatrics: parental health-related quality of life—results from the Care Project. Pediatrics, 122(5), e1030–e1038.
Haywood, K. L. (2006). Patient-reported outcome I: measuring what matters in musculoskeletal care. Musculoskeletal Care, 4(4), 187–203.
Hollin, I. L., Peay, H. L., & Bridges, J. F. (2014). Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis. The Patient, Dec 19. Epub ahead of print.
Johnson, F. R., Hauber, A. B., & Poulos, C. M. (2009). A brief introduction to the use of stated-choice methods to measure preferences for treatment benefits and risks. RTI Press publication No. RR-0009-0909. Research Triangle Park: RTI International. Retrieved from https://doi.org/www.rti.org/rtipress. Accessed December 2014.
Kenneson, A., & Bobo, J. K. (2010). The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy. Health & Social Care in the Community, 18(5), 520–528.
Landfeldt, E., Lindgren, P., Bell, C. F., Schmitt, C., Guglieri, M., Straub, V., Lochmüller, H., & Bushby, K. (2014). The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology, 83(6), 529–536.
Lee, J. A., Soutar, G., & Louviere, J. J. (2007). Measuring values using best worst scaling: the LOV example. Psychology and Marketing, 24(12), 1043–1058.
Louviere, J. J., & Flynn, T. N. (2010). Using best- worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in Australia. The Patient, 3, 275–283.
Louviere, J. J., & Islam, T. (2008). A comparison of importance weights and willingness-to-pay measures derived from choice-based conjoint, constant sum scales and best-worst scaling. Journal of Business Research, 61(9), 903–911.
Magnan, R. E., Köblitz, A. R., Zielke, D. J., & McCaul, K. D. (2009). The effects of warning smokers on perceived risk, worry, and motivation to quit. Annals of Behavioral Medicine, 37(1), 46–57.
McAndrew, L. M., Musumeci-Szabo, T. J., Mora, P. A., Vileikyte, L., Burns, E., Halm, E. A., Leventhal, E. A., & Leventhal, H. (2008). Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. British Journal of Health Psychology, 13(2), 195–204.
McAndrew, L. M., Mora, P. A., Quigley, K. S., Leventhal, E. A., & Leventhal, H. (2014). Using the common sense model of self-regulation to understand the relationship between symptom reporting and trait negative affect. International Journal of Behavioral Medicine, 21(6), 989–994.
McCaul, K. D., & Goetz, P. W. (2008). Worry. Health behavior constructs: Theory, measurement & research, National Cancer Institute. Retrieved from https://doi.org/cancercontrol.cancer.gov/brp/constructs/worry/index.html. Accessed December 2014.
Molassiotis, A., Emsley, R., Ashcroft, D., Caress, A., Ellis, J., Wagland, R., Bailey, C. D., et al. (2012). Applying best-worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer. Lung Cancer, 77(1), 199–204.
Murray, L. (2014). Left out in the cold: Barriers to clinical trial participation and the impact on parents of sons with Duchenne muscular dystrophy. Published Abstract, National Society of Genetic Counselors Annual Conference, Presented September 20, 2014.
Optum SF-12v2 Health Survey: Advantages of Norm-Based Scoring. (n.d.) Retrieved from https://doi.org/www.optum.com/content/dam/optum/resources/Manual%20Excerpts/Norm-based%20Scoring%20(NBS).pdf. Accessed December 2014.
Pangalila, R. F., van den Bos, G. A., Stam, H. J., van Exel, N. J., Brouwer, W. B., & Roebroeck, M. E. (2012). Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy. Disability and Rehabilitation, 34(12), 988–996.
Peay, H. L., Hollin, I., Fischer, R., & Bridges, J. F. (2014a). A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clinical Therapeutics, 36(5), 624–637.
Peay, H. L., Tibben, A., Fisher, T., Brenna, E., & Biesecker, B. B. (2014b). Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy. Clinical Trials, 11(1), 77–85.
Politi, M. C., & Street, R. L. (2011). The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty. Journal of Evaluation in Clinical Practice, 17(4), 579–584.
Razafsha, M., Behforuzi, H., Azari, H., Zhang, Z., Wang, K. K., Kobeissy, F. H., & Gold, M. S. (2012). Qualitative versus quantitative methods in psychiatric research. In: F. H. Kobeissy (Ed.), Psychiatric disorders: Methods and protocols, Methods in Molecular Biology, 829, 49–62.
Reid, D. T., & Renwick, R. M. (2001). Relating familial stress to the psychosocial adjustment of adolescents with Duchenne muscular dystrophy. International Journal of Rehabilitation Research, 24(2), 83–93.
Ross, M., Bridges, J., Ng, X., Wagner, L., Frosch, E., Reeves, G., & dosReis, S. (2015). A best-worst scaling experiment to prioritize caregiver concerns with attention deficit/hyperactivity disorder (ADHD) medicine for children. Psychiatric Services. doi:https://doi.org/10.1176/appi.ps.201300525.
U.S. Food and Drug Administration (FDA). (n.d.) Enhancing benefit-risk assessment in regulatory decision-making. Retrieved from https://doi.org/www.fda.gov/forindustry/userfees/prescriptiondruguserfee/ucm326192.htm. Accessed March 2014.
Uzark, K., King, E., Cripe, L., Spicer, R., Sage, J., Kinnett, K., Wong, B., et al. (2012). Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics, 130, 1–8.
Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12 item short form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.
Acknowledgments
We appreciate the leadership and commitment of the Parent Project Muscular Dystrophy oversight committee: Pat Furlong, Brian Denger, Sharon Hesterlee, and Kathleen Kinnett. We are indebted to the stakeholder informants, parents who participated in the cognitive interviews, and caregivers who completed the survey. We acknowledge Aad Tibben’s review and comments and Hadar Scharff’s study assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance with Ethical Standards
Conflict of Interest This study was funded by Parent Project Muscular Dystrophy (PPMD). Holly Landrum Peay was an employee of PPMD during the study development, data collection, and manuscript writing, and John FP Bridges was hired as a consultant by PPMD for this project. Ilene L. Hollin has no conflicts to disclose.
Human Studies and Informed Consent All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Studies No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Peay, H.L., Hollin, I.L. & Bridges, J.F.P. Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling. J Genet Counsel 25, 305–313 (2016). https://doi.org/10.1007/s10897-015-9872-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-015-9872-2